These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15468377)

  • 21. The clinical spectrum and treatment options of macrophage activation syndrome in the pediatric age.
    Stabile A; Bertoni B; Ansuini V; La Torraca I; Sallì A; Rigante D
    Eur Rev Med Pharmacol Sci; 2006; 10(2):53-9. PubMed ID: 16705949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage activation syndrome in juvenile idiopathic arthritis.
    Cortis E; Insalaco A
    Acta Paediatr Suppl; 2006 Jul; 95(452):38-41. PubMed ID: 16801165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical progression of apparent juvenile rheumatoid arthritis to systemic lupus erythematosus.
    Ragsdale CG; Petty RE; Cassidy JT; Sullivan DB
    J Rheumatol; 1980; 7(1):50-5. PubMed ID: 7354469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etanercept in the treatment of macrophage activation syndrome.
    Prahalad S; Bove KE; Dickens D; Lovell DJ; Grom AA
    J Rheumatol; 2001 Sep; 28(9):2120-4. PubMed ID: 11550985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case report of macrophage activation syndrome complicated by systemic onset juvenile idiopathic arthritis].
    Zhao Y; Cao LF
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Dec; 9(6):610. PubMed ID: 18082055
    [No Abstract]   [Full Text] [Related]  

  • 26. [A case of macrophage activation syndrome developed with systemic juvenile rheumatoid arthritis].
    Imagawa T; Katakura S; Mori M; Aihara Y; Mitsuda T; Yokota S
    Ryumachi; 1997 Jun; 37(3):487-92. PubMed ID: 9256033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute liver failure in young children with systemic-onset juvenile idiopathic arthritis without macrophage activation syndrome: report of two cases.
    Hiejima E; Komatsu H; Takeda Y; Sogo T; Inui A; Okafuji I; Nishikomori R; Nakahata T; Fujisawa T
    J Paediatr Child Health; 2012 Mar; 48(3):E122-5. PubMed ID: 22050445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
    Ravelli A; Caria MC; Buratti S; Malattia C; Temporini F; Martini A
    J Rheumatol; 2001 Apr; 28(4):865-7. PubMed ID: 11327264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longterm outcome of amyloidosis associated with juvenile idiopathic arthritis.
    Immonen K; Savolainen A; Kautiainen H; Hakala M
    J Rheumatol; 2008 May; 35(5):907-12. PubMed ID: 18381779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophage activation syndrome in children with systemic-onset juvenile chronic arthritis.
    Kounami S; Yoshiyama M; Nakayama K; Okuda M; Okuda S; Aoyagi N; Yoshikawa N
    Acta Haematol; 2005; 113(2):124-9. PubMed ID: 15802891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis.
    Verbsky JW; White AJ
    J Rheumatol; 2004 Oct; 31(10):2071-5. PubMed ID: 15468378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anakinra for systemic juvenile arthritis: the Rocky Mountain experience.
    Zeft A; Hollister R; LaFleur B; Sampath P; Soep J; McNally B; Kunkel G; Schlesinger M; Bohnsack J
    J Clin Rheumatol; 2009 Jun; 15(4):161-4. PubMed ID: 19363453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under-recognized complication?
    Pringe A; Trail L; Ruperto N; Buoncompagni A; Loy A; Breda L; Martini A; Ravelli A
    Lupus; 2007; 16(8):587-92. PubMed ID: 17711893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The incidence of macrophage activation syndrome in children with rheumatic disorders.
    Moradinejad MH; Ziaee V
    Minerva Pediatr; 2011 Dec; 63(6):459-66. PubMed ID: 22075800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome.
    Fall N; Barnes M; Thornton S; Luyrink L; Olson J; Ilowite NT; Gottlieb BS; Griffin T; Sherry DD; Thompson S; Glass DN; Colbert RA; Grom AA
    Arthritis Rheum; 2007 Nov; 56(11):3793-804. PubMed ID: 17968951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effectiveness of systemic immunoglobulins in the treatment of the systemic variants of juvenile rheumatoid arthritis].
    Alekseeva EI; Shakhbazian IE; Zholobova KB
    Klin Med (Mosk); 2001; 79(2):26-9. PubMed ID: 11419080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural killer cell dysfunction: A common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis?
    Grom AA
    Arthritis Rheum; 2004 Mar; 50(3):689-98. PubMed ID: 15022306
    [No Abstract]   [Full Text] [Related]  

  • 38. Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis.
    Lehmberg K; Pink I; Eulenburg C; Beutel K; Maul-Pavicic A; Janka G
    J Pediatr; 2013 Jun; 162(6):1245-51. PubMed ID: 23333131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis?
    Ramanan AV; Grom AA
    Rheumatology (Oxford); 2005 Nov; 44(11):1350-3. PubMed ID: 15956091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical picture of renal pathology in children with infectious nonspecific (rheumatoid) polyarthritis].
    Dumnova AG; Volkova LD
    Vopr Okhr Materin Det; 1968 Jun; 13(6):22-6. PubMed ID: 5719539
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.